Rheumatoid Arthritis Recruiting Phase Trials for Certolizumab pegol (DB08904)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03016260RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
NCT02714881Lipids, Inflammation, and CV Risk in RAPrevention
NCT02620189Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα